Updated
Updated · STAT · Jun 9
NIH Names John Powers III to Lead $6.5 Billion Infectious Disease Institute
Updated
Updated · STAT · Jun 9

NIH Names John Powers III to Lead $6.5 Billion Infectious Disease Institute

3 articles · Updated · STAT · Jun 9

Summary

  • John Powers III was appointed acting director of the National Institute of Allergy and Infectious Diseases, ending weeks of uncertainty after reports that Jeffery Taubenberger had stepped down.
  • The move fills a leadership gap at NIH’s second-largest agency, which has lacked a permanent chief since Jeanne Marrazzo was ousted in March.
  • Powers had served as a senior adviser at NIAID and as Taubenberger’s deputy; NIH told staff he brings experience in clinical infectious diseases, research, regulatory science and public health leadership.
  • The appointment comes as lawmakers question NIH’s infectious-disease bench after several senior leaders were reassigned, with concern heightened by a hantavirus outbreak and an Ebola outbreak in Central Africa.

Insights

With its leadership in turmoil, is America's top disease institute losing its focus on preventing the next pandemic?
As a new Ebola strain spreads without a vaccine, can a shaken NIAID accelerate the race for a cure?